Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis

Published:2021-05 Issue: Volume:137 Page:111342
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Peng Wei,Cheng Shumin,Bao Zhihang,Wang Youjing,Zhou Wei,Wang Junxian,Yang Qingling,Chen Changjie,Wang Wenrui

Funder

Bengbu Medical College

Scientific Research Foundation of Education Department of Anhui Province of China

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference81 articles.

1. Liver fibrosis;Aydin;Turk. J. Gastroenterol.,2018

2. Pathobiology of liver fibrosis: a translational success story;Lee;Gut,2015

3. Reversal of liver fibrosis: from fiction to reality;Zoubek;Best Pract. Res. Clin. Gastroenterol.,2017

4. Recent advances in nanomedicine for the diagnosis and therapy of liver fibrosis;Bai;Nanomaterials,2020

5. New concepts on reversibility and targeting of liver fibrosis; a review article;Ebrahimi;Middle East J. Dig. Dis.,2018

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-Ligand-Modified Nanoscale Liposomes Co-Encapsulating Aspirin and Curcumin Inhibit Platelet-Induced Tumor Proliferation and Metastasis;ACS Applied Nano Materials;2024-06-07

2. Research Progress in Natural Products against Liver Fibrosis;The Natural Products Journal;2024-06-04

3. Recruitment or activation of mast cells in the liver aggravates the accumulation of fibrosis in carbon tetrachloride-induced liver injury;Molecular Immunology;2024-06

4. Liver fibrosis pathologies and potentials of RNA based therapeutics modalities;Drug Delivery and Translational Research;2024-03-06

5. The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver Fibrosis;Advanced Materials;2023-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3